Skip to content Skip to footer
Join our LinkedIn Group and be part of the conversation on AI in life sciences
Login
Login
Close

Meghan Oates-Zalesky 

Meghan Oates‑Zalesky is Chief Marketing Officer at CapeStart and MadeAi, with over 20 years of experience in healthcare technology and life sciences. Previously CMO at Apollo Intelligence, she helped grow the company from a small startup into a global enterprise. A PharmaVOICE Woman of Influence (2021), Meg’s thought leadership has appeared in leading industry publications. She holds degrees from Harvard and the London School of Economics and is a published novelist and avid equestrian.

98 articles published Follow:
research

AI Strategy Readiness: Insights on Team Capabilities and Vendor Support (CapeStart Report)

BlogJanuary 6, 2025339Views0Likes0Comments
Artificial Intelligence (AI) holds immense promise, but its successful adoption depends on two critical factors: whether teams have the capability to implement AI strategies and whether they can access the right vendor support. CapeStart’s Life Science AI Research Report sheds light on these questions, offering a deeper understanding of how organizations are navigating these challenges.…

Read More

MadeAi | AI Initiatives in Action: Insights from CapeStart's Life Science AI Research Report

AI Initiatives in Action: Insights from CapeStart’s Life Science AI Research Report

BlogDecember 17, 2024227Views0Likes0Comments
Artificial Intelligence (AI) is no longer a concept of the future—it's firmly entrenched in the here and now. CapeStart’s Life Science AI Research Report examines how actively life science professionals involved in AI initiatives. The findings underscore how AI is gradually transforming businesses, particularly in the life sciences industry. Engagement in AI Initiatives: A Snapshot…

Read More

lr

Life Science Professionals’ Perspectives on AI: Insights from CapeStart’s GenAI Report

BlogDecember 10, 2024230Views0Likes0Comments
Artificial Intelligence (AI) is making waves in industries worldwide, but how do professionals in life sciences feel about its potential? According to CapeStart’s Life Science AI Research Report, a resounding 91% of respondents believe that AI can assist and empower their work. This overwhelming optimism highlights a strong recognition of AI’s transformative capabilities. Belief in…

Read More

How CapeStart Streamlined Literature Review at Top 20 Pharmaceutical Manufacturer with GenAI-enabled Solution

CapeStart’s GenAI Solution Streamlines Literature Review for Top 20 Pharmaceutical Manufacturer

Case StudyDecember 2, 2024305Views0Likes0Comments
The clinical team for existing products at “ABC Pharma,” a top 20 pharmaceutical manufacturer, needed an automated solution for processing large volumes of medical literature across multiple therapeutic areas. Their internal development efforts had proved costly and unsuccessful. Requiring a comprehensive platform that could handle diverse literature types, support Health Authority inquiries, process content across ten…

Read More